FHIR IG analytics| Package | lt.hl7.fhir.prostate |
| Resource Type | ConceptMap |
| Id | ConceptMap-conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate.json |
| FHIR Version | R5 |
| Source | https://build.fhir.org/ig/HL7LT/ig-lt-prostate/ConceptMap-conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate.html |
| URL | https://hl7.lt/fhir/prostate/ConceptMap/prostate-pathology-questionnaire-to-fhir |
| Version | 0.1.0 |
| Status | draft |
| Date | 2025-03-24 |
| Name | ProstatePathologyQuestionnaireToFhir |
| Title | Prostate pathology Questionnaire items to FHIR mapping |
| Description | Maps dr-prostate-aligned pathology Questionnaire linkIds to LT Lab and LT Prostate Gleason/ISUP patterns. |
No resources found
| CodeSystem | ||
| lt.hl7.fhir.prostate#current | prostate-fhir-mapping-target | Prostate questionnaire → FHIR mapping target (illustrative) |
| lt.hl7.fhir.prostate#current | prostate-pathology-questionnaire-item | Prostate pathology ESPBI Questionnaire item (linkId) |
Note: links and images are rebased to the (stated) source
English
Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate
Language: en
Mapping from (not specified) to (not specified)
Group 1 Mapping from Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1) to Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)
| Source Code | Relationship | Target Code | Comment |
| bioptate-length-mm (Bioptate length (mm)) | is related to | specimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross)) | Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab). |
| specimen-quality (Quality of materials) | is related to | specimen-adequacy-finding (Observation: specimen adequacy (LT Lab)) | Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec. |
| treatment-effect (Treatment effect on tumour) | is related to | observation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab)) | TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet. |
| histological-type (Primary histological type) | is related to | condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O)) | Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging. |
| histological-comment (Histological type comment) | is related to | condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O)) | Condition.note or Observation.note; complements histological-type. |
| isup-grade-group | is related to | observation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS) | GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example. |
| idc-status (Intraductal carcinoma (IDC)) | is related to | observation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC) | TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions. |
| cribriform-status (Cribriform glands) | is related to | observation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform) | TumorObservableLtLab or structured finding Observation. |
| pattern4-pct-band (Pattern 4 quantity (percent band)) | is related to | observation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns)) | TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire. |
| tumor-percent-in-biopsy (Tumour percentage in biopsy tissue) | is related to | observation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue) | Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category. |
| periprostatic-fat-invasion | is related to | observation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings)) | NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy. |
| perineural-invasion | is related to | observation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings)) | SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings. |
| lymphovascular-invasion (Lymphatic and/or vascular tumour invasion) | is related to | observation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings)) | SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment. |
Lithuanian
Generated Narrative: ConceptMap conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate
Language: en
Mapping from (not specified) to (not specified)
Group 1 Mapping from Prostate pathology ESPBI Questionnaire item (linkId)version: 0.0.1) to Prostate questionnaire → FHIR mapping target (illustrative)version: 0.0.1)
| Source Code | Relationship | Target Code | Comment |
| bioptate-length-mm (Bioptate length (mm)) | is related to | specimen-dimension-or-measurement (Specimen / Observation specimen measurement (TumorMeasurementLtLab, gross)) | Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab). |
| specimen-quality (Quality of materials) | is related to | specimen-adequacy-finding (Observation: specimen adequacy (LT Lab)) | Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec. |
| treatment-effect (Treatment effect on tumour) | is related to | observation-tumor-treatment-effect (Observation: tumor treatment effect (TumorObservableLtLab)) | TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet. |
| histological-type (Primary histological type) | is related to | condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O)) | Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging. |
| histological-comment (Histological type comment) | is related to | condition-morphology-prostate (Condition / morphology (ProstateConditionLtLab, ICD-O)) | Condition.note or Observation.note; complements histological-type. |
| isup-grade-group | is related to | observation-gleason-isup-prostate (GleasonIsupObservationLtProstate + ProstateIsupGradeGroupVS) | GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example. |
| idc-status (Intraductal carcinoma (IDC)) | is related to | observation-tumor-microscopic-idc (TumorObservableLtLab / morphology for IDC) | TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions. |
| cribriform-status (Cribriform glands) | is related to | observation-tumor-microscopic-cribriform (TumorObservableLtLab / morphology for cribriform) | TumorObservableLtLab or structured finding Observation. |
| pattern4-pct-band (Pattern 4 quantity (percent band)) | is related to | observation-pattern4-percent (Observation: Pattern 4 percent band (lab tumour measurement patterns)) | TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire. |
| tumor-percent-in-biopsy (Tumour percentage in biopsy tissue) | is related to | observation-tumor-burden-percent (Observation: tumour percentage in biopsy tissue) | Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category. |
| periprostatic-fat-invasion | is related to | observation-periprostatic-invasion (Observation: periprostatic fat / seminal vesicle invasion (LT Lab tumour findings)) | NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy. |
| perineural-invasion | is related to | observation-perineural-invasion (Observation: perineural invasion finding (LT Lab tumour findings)) | SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings. |
| lymphovascular-invasion (Lymphatic and/or vascular tumour invasion) | is related to | observation-lymphovascular-invasion (Observation: lymphovascular invasion finding (LT Lab tumour findings)) | SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment. |
{
"resourceType": "ConceptMap",
"id": "conceptmap-prostate-pathology-questionnaire-to-fhir-lt-prostate",
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://hl7.lt/fhir/prostate/ConceptMap/prostate-pathology-questionnaire-to-fhir",
"version": "0.1.0",
"name": "ProstatePathologyQuestionnaireToFhir",
"title": "Prostate pathology Questionnaire items to FHIR mapping",
"status": "draft",
"experimental": true,
"date": "2025-03-24",
"publisher": "Lithuanian Medical Library",
"contact": [
{
"name": "Lithuanian Medical Library",
"telecom": [
{
"system": "url",
"value": "https://medicinosnk.lt"
},
{
"system": "email",
"value": "info@medicinosnk.lt"
}
]
}
],
"description": "Maps dr-prostate-aligned pathology Questionnaire linkIds to LT Lab and LT Prostate Gleason/ISUP patterns.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "LT"
}
]
}
],
"group": [
{
"source": "https://tx.hl7.lt/fhir/CodeSystem/prostate-pathology-questionnaire-item|0.0.1",
"target": "https://tx.hl7.lt/fhir/CodeSystem/prostate-fhir-mapping-target|0.0.1",
"element": [
{
"code": "bioptate-length-mm",
"display": "Bioptate length (mm)",
"target": [
{
"code": "specimen-dimension-or-measurement",
"relationship": "related-to",
"comment": "Specimen dimension or Observation-observation-specimen-measurement-example (LT Lab)."
}
]
},
{
"code": "specimen-quality",
"display": "Quality of materials",
"target": [
{
"code": "specimen-adequacy-finding",
"relationship": "related-to",
"comment": "Observation-observation-specimen-adequacy-example (LT Lab); map answerCoding to SNOMED finding codes from national spec."
}
]
},
{
"code": "treatment-effect",
"display": "Treatment effect on tumour",
"target": [
{
"code": "observation-tumor-treatment-effect",
"relationship": "related-to",
"comment": "TumorObservableLtLab or narrative in DiagnosticReport; map radiotherapy/hormone SNOMED from spreadsheet."
}
]
},
{
"code": "histological-type",
"display": "Primary histological type",
"target": [
{
"code": "condition-morphology-prostate",
"relationship": "related-to",
"comment": "Condition.code / morphology; Condition-condition-prostate-cancer-example (LT Lab) for integrated staging."
}
]
},
{
"code": "histological-comment",
"display": "Histological type comment",
"target": [
{
"code": "condition-morphology-prostate",
"relationship": "related-to",
"comment": "Condition.note or Observation.note; complements histological-type."
}
]
},
{
"code": "isup-grade-group",
"display": "ISUP grade group",
"target": [
{
"code": "observation-gleason-isup-prostate",
"relationship": "related-to",
"comment": "GleasonIsupObservationLtProstate + ValueSet prostate-isup-grade-group. Example: Observation-observation-prostate-gleason-gradegroup-example."
}
]
},
{
"code": "idc-status",
"display": "Intraductal carcinoma (IDC)",
"target": [
{
"code": "observation-tumor-microscopic-idc",
"relationship": "related-to",
"comment": "TumorObservableLtLab / morphology Observation; national form has additional IDC sub-questions."
}
]
},
{
"code": "cribriform-status",
"display": "Cribriform glands",
"target": [
{
"code": "observation-tumor-microscopic-cribriform",
"relationship": "related-to",
"comment": "TumorObservableLtLab or structured finding Observation."
}
]
},
{
"code": "pattern4-pct-band",
"display": "Pattern 4 quantity (percent band)",
"target": [
{
"code": "observation-pattern4-percent",
"relationship": "related-to",
"comment": "TumorMeasurementLtLab or lab tumour Observation; dr-prostate has finer bands than this Questionnaire."
}
]
},
{
"code": "tumor-percent-in-biopsy",
"display": "Tumour percentage in biopsy tissue",
"target": [
{
"code": "observation-tumor-burden-percent",
"relationship": "related-to",
"comment": "Quantitative tumour assessment row in dr-prostate; map to Observation ratio or coded category."
}
]
},
{
"code": "periprostatic-fat-invasion",
"display": "Periprostatic fat invasion",
"target": [
{
"code": "observation-periprostatic-invasion",
"relationship": "related-to",
"comment": "NeoplasmInvasionLtProstate (imaging) vs microscopic finding in pathology Observation; use LT Lab tumour findings for biopsy."
}
]
},
{
"code": "perineural-invasion",
"display": "Perineural invasion",
"target": [
{
"code": "observation-perineural-invasion",
"relationship": "related-to",
"comment": "SNOMED 369731000 (present), 370051000 (absent), 385001000 (not identified), 396393005 (indeterminate); use LT Lab tumour findings."
}
]
},
{
"code": "lymphovascular-invasion",
"display": "Lymphatic and/or vascular tumour invasion",
"target": [
{
"code": "observation-lymphovascular-invasion",
"relationship": "related-to",
"comment": "SNOMED 385414009 Lymphatic (small vessel) tumor invasion finding; use LT Lab tumour findings for biopsy microscopic assessment."
}
]
}
]
}
]
}